TB Prevention

This information sheet discusses the bacille Calmette-Guerin (BCG) vaccine for TB, which is used in many countries to prevent childhood tuberculous meningitis and miliary TB. It explains why the BCG is not generally recommended for use in the United States; suggests that the BCG should be considered under specific circumstances; and provides recommendations for when the BCG should be used with children and health care workers, and contraindications when it should not be used, such as for immunosuppressed persons and pregnant women.

This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at risk of MDR or XDR TB while traveling, the risk of acquiring TB on an airplane, how TB can be prevented, TB vaccine, and what an individual should do before traveling internationally and if an individual thinks that he/she may have been exposed to someone with TB disease.

This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at risk of MDR or XDR TB while traveling, the risk of acquiring TB on an airplane, how TB can be prevented, TB vaccine, and what an individual should do before traveling internationally and if an individual thinks that he/she may have been exposed to someone with TB disease.

This information sheet discusses TB and how it is affected by HIV. It defines TB and explains the difference between TB infection and TB disease. The information sheet advises that HIV weakens the immune system, increasing the chance that in people with HIV and latent TB, the TB germs will become active and attack the body, causing TB disease. It emphasizes the importance of TB treatment and taking the TB drugs as prescribed.

This information sheet discusses TB in Hispanics/Latinos. It explains TB disease the incidence of TB disease in Hispanics/Latinos for 2011 including the reported TB cases by origin and race/ethnicity in the United States 2011. The information sheet explains challenges faced in preventing TB including socioeconomic factors, language and cultural barriers, stigma associated with the disease and other underlying medical conditions that may increase the risk of latent TB becoming active disease. It describes what CDC is doing to achieve TB elimination.

This document is intended for use as a reference manual for clinicians caring for persons with or at high risk for TB disease or infection. It is not meant to provide detailed answers to all public health or clinical questions about TB, and it is not meant as a substitute for any specific guidelines.

This information sheet discusses how CDC is working to prevent extensively drug-resistant TB (XDR TB).

This report serves as a handbook or primer, for nongovernmental organizations and civil society organizations (CSOs) considering joining the fight against TB. It provides informaton on TB and its prevention, diagnosis, and treatment and how TB programs work, how communities and CSOs can get involved, and on special populations that need extra attention. It includes step-by-step guidance on getting started in addressing TB, pitfalls to avoid, and a list of useful resources.

This poster in black, grey, and white, promotes World TB Day March 24, 2014. World TB Day provides an opportunity to raise awareness about TB and to support the worldwide fight against TB.

This poster in black, grey, and white, promotes World TB Day March 24, 2014. World TB Day provides an opportunity to raise awareness about TB and to support the worldwide fight against TB.